Transcriptome analysis of recurrently deregulated genes across multiple cancers identifies new pan-cancer biomarkers
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Transcriptome analysis of recurrently deregulated genes across multiple cancers identifies new pan-cancer biomarkers. / Kaczkowski, Bogumil; Tanaka, Yuji; Kawaji, Hideya; Sandelin, Albin Gustav; Andersson, Robin; Itoh, Masayoshi; Lassmann, Timo; the FANTOM5 consortium; Hayashizaki, Yoshihide; Carninci, Piero; Forrest, Alistair R. R.
In: Cancer Research, Vol. 76, No. 2, 2016, p. 216-226.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Transcriptome analysis of recurrently deregulated genes across multiple cancers identifies new pan-cancer biomarkers
AU - Kaczkowski, Bogumil
AU - Tanaka, Yuji
AU - Kawaji, Hideya
AU - Sandelin, Albin Gustav
AU - Andersson, Robin
AU - Itoh, Masayoshi
AU - Lassmann, Timo
AU - the FANTOM5 consortium, null
AU - Hayashizaki, Yoshihide
AU - Carninci, Piero
AU - Forrest, Alistair R. R.
N1 - Copyright © 2015, American Association for Cancer Research.
PY - 2016
Y1 - 2016
N2 - Genes that are commonly deregulated in cancer are clinically attractive as candidate pan-diagnostic markers and therapeutic targets. To globally identify such targets, we compared Cap Analysis of Gene Expression (CAGE) profiles from 225 different cancer cell lines and 339 corresponding primary cell samples to identify transcripts that are deregulated recurrently in a broad range of cancer types. Comparing RNA-seq data from 4,055 tumors and 563 normal tissues profiled in the TCGA and FANTOM5 datasets, we identified a core transcript set with theranostic potential. Our analyses also revealed enhancer RNAs which are upregulated in cancer, defining promoters which overlap with repetitive elements (especially SINE/Alu and LTR/ERV1 elements) that are often upregulated in cancer. Lastly, we documented for the first time upregulation of multiple copies of the REP522 interspersed repeat in cancer. Overall, our genome-wide expression profiling approach identified a comprehensive set of candidate biomarkers with pan-cancer potential, and extended the perspective and pathogenic significance of repetitive elements which are frequently activated during cancer progression.
AB - Genes that are commonly deregulated in cancer are clinically attractive as candidate pan-diagnostic markers and therapeutic targets. To globally identify such targets, we compared Cap Analysis of Gene Expression (CAGE) profiles from 225 different cancer cell lines and 339 corresponding primary cell samples to identify transcripts that are deregulated recurrently in a broad range of cancer types. Comparing RNA-seq data from 4,055 tumors and 563 normal tissues profiled in the TCGA and FANTOM5 datasets, we identified a core transcript set with theranostic potential. Our analyses also revealed enhancer RNAs which are upregulated in cancer, defining promoters which overlap with repetitive elements (especially SINE/Alu and LTR/ERV1 elements) that are often upregulated in cancer. Lastly, we documented for the first time upregulation of multiple copies of the REP522 interspersed repeat in cancer. Overall, our genome-wide expression profiling approach identified a comprehensive set of candidate biomarkers with pan-cancer potential, and extended the perspective and pathogenic significance of repetitive elements which are frequently activated during cancer progression.
U2 - 10.1158/0008-5472.CAN-15-0484
DO - 10.1158/0008-5472.CAN-15-0484
M3 - Journal article
C2 - 26552699
VL - 76
SP - 216
EP - 226
JO - Cancer Research
JF - Cancer Research
SN - 0008-5472
IS - 2
ER -
ID: 147665590